Andrew Sassine
Board of Director
Finance
Gemphire
United States of America
Biography
Mr. Sassine has served as a member of board of directors since May 2015. Mr. Sassine served in various positions at Fidelity Investments from 1999 to 2012, rising to the position of Portfolio Manager. Prior to joining Fidelity, he served as a vice president in the Acquisition Finance Group at Fleet National Bank. Mr. Sassine serves on the board of directors of two other public companies: iCAD, Inc. (NASDAQ:ICAD), an industry leading provider of advanced image analysis, workflow solutions and radiation therapy for the early detection and treatment of cancer; and MYnd Analytics, Inc. (OTC: CNSO), a predictive analytics company that provides objective clinical decision support to mental health care provider for the personalized treatment of behavioral disorders. Mr. Sassine also serves on the board of directors of two private companies: Freedom Meditech, Inc., a medical device company focused on the development and commercialization of first-to-market non-invasive ophthalmic medical devices that can screen for diabetes up to six years prior to the onset of the disease; and Comhear Inc., a digital audio software and device company, where he is also the Chairman of the Board. Mr. Sassine has been a member of the Henry B. Tippie College of Business, University of Iowa Board of Advisors since 2009 and served on the Board of Trustees at the Clarke Schools for Hearing and Speech from 2009 through 2014. Mr. Sassine holds a Bachelor of Arts degree at the University of Iowa and an MBA from the Wharton School at the University of Pennsylvania.
Research Interest
Medical device,Clinical decision support to mental health care,